FRENCH pharmaceuticals group Sanofi-Synthelabo last night agreed the £32bn-plus takeover of rival Aventis, creating the world's third-largest drug company.
Create a FREE account to continue reading
Registration is a free and easy way to support our journalism.
Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.
Thank you for registering
Please refresh the page or navigate to another page on the site to be automatically logged in